In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cambridge Epigenetix Ltd.

www.cambridge-epigenetix.com

Latest From Cambridge Epigenetix Ltd.

Cambridge Epigenetix Boosts Senior Leadership Team With New Hires

Cambridge Epigenetix Ltd. (CEGX) has appointed two new senior executives to help drive development of its epigenetics-based diagnostic technologies. Hayden Jeffreys joins the company as COO and Joanne Mason as vice president of biomarker discovery.

Diagnostics Appointments

Pacts In Medtech: March/April 2017

Derived from Strategic Transactions, Informa’s premium source for tracking life-sciences deals, the bi-monthly Pacts In Medtech column pulls up notable technology alliances, R&D partnerships and commercial collaborations. In this edition, we highlight industry pacts that were sealed in March and April 2017.

Deals Pacts in Medtech

Execs On The Move, April 2017

Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.

Appointments Leadership

Venture Funding Deals, April 2016

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a monthly review of emerging In Vitro Diagnostic, Medical Device, and Pharmaceutical companies that have received venture funding. This month’s column covers deals announced February through March 2016.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • Genomics-Proteomics
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
  • Research, Analytical Equipment & Supplies
  • Services
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • UK
  • Parent & Subsidiaries
  • Cambridge Epigenetix Ltd.
  • Senior Management
  • Jason Mellad, PhD, CEO
    Michael Steward, PhD, Dir., R&D
    Deborah Tonge, Dir., Fin. & Operations
  • Contact Info
  • Cambridge Epigenetix Ltd.
    Phone: 1223 804260
    Babraham Campus
    Jonas Webb Bldg
    Cambridge, CB22 3AT
    UK
UsernamePublicRestriction

Register